Publication:
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

No Thumbnail Available

Date

2019-01-01T00:00:00Z

Authors

Esen, Ramazan
Cekdemir, Demet
Guvenc, Serkan
Ozdemirkiran, Fusun
Eser, Ali
Topts, Tayfur
ÖZKOCAMAN, VİLDAN
ŞAHİN, HANDAN HAYDAROĞLU
ERMİŞ TURAK, Esra
Comert, Melda

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).

Description

Keywords

Citation

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., ŞAHİN H. H. , ERMİŞ TURAK E., Esen R., Comert M., et al., -A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience-, TURKISH JOURNAL OF HEMATOLOGY, cilt.36, ss.230-237, 2019
Page Views

2

File Downloads

0

Sustainable Development Goals